Board Bios

Marna O. Davis, Co-Chairman

Marna Davis graduated from St. Lawrence University. After working in government and in the financial printing business, Marna went through the commercial banking training program at The Bankers Trust Company, and worked in their National Banking Department. Marna has been involved in many volunteer activities including her sons’ school and sports worlds.  She served on the board of the Greenwich Adult Day Care Center, and is currently on the board of The Shelburne Museum in Vermont. Marna is chairman of the Board of the Fibrolamellar Cancer Foundation. Marna and her husband Chuck lost their son, Tucker, to fibrolamellar when he was 28 years old. Tucker was the founder of this Foundation.


John Hopper, Executive Director

John Hopper is a graduate of the College of the Holy Cross and Oxford University’s executive MBA program. He launched his career with Procter and Gamble in sales management and Unilever as division head of a $1 billion business unit. John served in CEO and Managing Partner positions with healthcare/marketing focused venture capital and communications conglomerates including Publicis, WPP Group, and Interpublic’s McCann Healthcare creating multi-million dollar profit centers focused on health/wellness professional and patient outreach. John also was a pioneer in partnering sports and entertainment celebrities/properties with health/wellness campaigns, such as the MLB, NFL, NBA, NHL, Larry King,  Magic Johnson, Joe Namath, Julie Andrews, and Jack Nicklaus.

John currently serves as the co-chairman of the GI Cancers Alliance and is on the board of the National Pancreas Foundation. John is the father of three adult children.


Charles A. Davis, Co-Chairman, Member

Chuck Davis is a graduate of The University of Vermont and Columbia University Graduate School of Business. Tucker, the founder of FCF, was Chuck’s son.

Chuck is the CEO of Stone Point Capital (SPC) in Greenwich, CT. SPC is a global private equity firm focusing on the financial services industry since 1994. SPC invests primarily through the Trident Funds, which have secured approximately $19 billion in committed capital for investments in more than fifty companies.

Before joining SPC in 1998, Chuck was a partner with Goldman Sachs & Co. for 23 years serving as head of Investment Banking Services worldwide, co-head of the Americas Group, head of the Financial Services Industry Group, and a member of the International Executive Committee.

Chuck is a director of AXIS Capital Holdings Limited, The Progressive Corporation and The Hershey Company.  He also serves on numerous boards of companies in the SPC portfolio. Former corporate directorships include Marsh & McLennan Companies, Inc.; Merchants Bancshares Inc.; and The US Life Corporation. His other non-profit directorships include, or have included, The University of Vermont, St. Michael’s College, and the Boys and Girls Club of Greenwich, CT.


David J. Wermuth, Member

David Wermuth holds a B.A. from Yale University, an M.B.A. from the New York University Leonard N. Stern School of Business and a J.D. from Cornell Law School. David is a Senior Principal of Stone Point and a member of the Investment Committees of the Trident Funds. He joined Stone Point in 1999 from Cleary, Gottlieb, Steen & Hamilton LLP where from 1996 to 1999 he was a corporate attorney specializing in mergers and acquisitions. Prior to joining Cleary Gottlieb, David served as a law clerk to a federal judge of the U.S. Court of Appeals for the Ninth Circuit and as an auditor for KPMG.


Anne Adler

Anne Adler, a graduate of Wheaton College and Boston College Law School, practiced securities law for 15 years. While raising 5 sons and a daughter she did volunteer work and was webmaster for Brunswick School working with the communications, alumni and development teams. Her volunteer work included serving on multiple boards acting as counsel and/or overseeing the organization’s website.  Anne has been President/Board Chair of The Keewaydin Foundation, Greenwich Skating Club, the Round Hill Guild and Round Hill Nursery School. She has also served on the parents boards of Brunswick School and Greenwich Academy, and on the boards of the Junior League of Greenwich, Women of Vision, the Round Hill Association and the Friends of Historic Huletts Landing. In addition to FCF’s board, Anne is currently on the board of Vermont Youth Conservation Corp. Anne’s sons went to school and played hockey with the Davis’ boys, hence her connection to FCF.


Charles W. Beermann, Founding Director

Charles Beermann is a graduate of Southern Methodist University. Charles, a long-time friend of FCF Founder Tucker Davis, helped co-found FCF in 2009. He has served on the Board of Directors since 2010 and currently serves on the FCF Development Committee. Charles is responsbile for the Foundation’s risk management. Charles is an executive with Berkshire Hathaway Specialty Insurance, based in Atlanta, GA where he resides.


John Craig, MD, PhD

John Craig attended UCLA and USC Medical School. After graduating medical school he entered a PhD program at USC studying liver regeneration, completing a residency in Pathology while doing the doctoral research. Subsequently Dr. Craig joined the faculty of the USC Medical School; he supervised an NIH grant and postgraduate students, as well as teaching medical students. Dr. Craig published numerous papers on liver disease, wrote several textbooks including the definitive book which classified and defined all types of liver neoplasms (AFIP Fascicle). In 1980 Dr. Craig created the name and published the first large series on Fibrolamellar Carcinoma. As an invited speaker to more that one hundred national and international conferences, Dr. Craig continues to describe this tumor and review the current research. He was a co-founder of Laennec Pathology Society, an international liver society, allowing him to meet expert liver pathologists around the world. Over his last ten years in practice Dr. Craig was the Medical Director of a community cancer center – St. Jude Medical Center in Fullerton, California. Dr. Craig remains active in the Leannec Pathology Society. Dr. Craig and his wife, a retired surgeon, live in Carmel, CA and France. Dr. Craig has been a passionate musician his whole life.


Derek Gilchrist, Founding Director

Derek Gilchrist a graduate of the University of Vermont and received his law degree from New York Law. Derek is General Counsel of Manhattan based real estate developer Sedesco Inc. In this role, Derek oversees Sedesco’s day to day operations, handling everything from acquisitions and development to leasing and asset management. Active in civic and philanthropic affairs, he co-founded FCF with his friend Tucker Davis and is dedicated to helping find a cure for this rare disease. Derek is also on the board of Cross Cultural Care. Derek is married with one small child living in New York City.



Leslie Graves

Leslie Graves graduated from Duke University with an AB degree in Economics. She received her MBA degree from the Colgate Darden Graduate School of Business Administration at the University of Virginia in 1985.

Leslie is a Managing Director and Co-Head of Origination and Syndicate at R. Seelaus & Co.  Prior to joining Seelaus, she was a Managing Director at Mischler Financial Group where she built their bank and finance capital markets business. Leslie spent the first 26 years of her career in financial services at First Boston which became Credit Suisse.

Leslie is married to JT Fucigna.  They live in Darien, CT and have three children.

Leslie also serves on the Board of Advisors of the Duke Cancer Institute.

Craig Martin

Craig Martin is CEO of health strategy and communications firm Feinstein Kean Healthcare (FKH), an Ogilvy company based in Cambridge, MA, with offices in other life science, health and technology hubs around the country.  He also serves as a Global Principal for Ogilvy RED, the agency’s consulting arm, leading the RED’s work in Biotech and Health Technology.  Craig is an advisor to leading and emerging biotech, pharmaceutical, diagnostic, health IT and other companies and advocacy organizations.  His background includes managing businesses, teams and consultancies based in Cambridge, New York, Washington, DC, and Brussels.  During the past decade in particular, Craig has spent considerable time working with companies and non-profit groups focused in rare disease and oncology.  He has also been a speaker and advisor on shifting advocacy models that reflect the new role of patients and their data in biomedical research and development. In addition to serving on the FCF board, Craig also serves on the board of Global Genes, a rare disease advocacy organization.


Alisha Sternenberger, Founding Director

Alisha Sternenberger holds a Bachelor of Arts degree from the University of Colorado, Boulder, an MBA from Babson College, and is actively enrolled in Boston College’s Clinical Research Certificate program. Alisha co-founded the FCF in 2009, and became a founding director. Originally from Colorado, Alisha lived in New York City for seven years before moving to Boston, where she currently resides. She is currently pursuing a career in the biotech/pharma space.